- Report
- May 2022
- 41 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- May 2022
- 37 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Book
- August 2023
- 224 Pages
- Book
- February 2024
- 928 Pages
- Book
- August 2023
- 368 Pages
- Book
- November 2008
- 496 Pages
- Book
- July 2019
- 480 Pages
The ABC Transporter market is a subset of the biotechnology industry that focuses on the development of proteins that transport molecules across cell membranes. These proteins, known as ATP-binding cassette (ABC) transporters, are essential for the transport of a variety of molecules, including drugs, toxins, and nutrients. ABC transporters are also involved in the regulation of gene expression and the maintenance of cellular homeostasis.
The ABC Transporter market is driven by the increasing demand for new drugs and therapies, as well as the need for improved drug delivery systems. Additionally, the development of new technologies, such as gene editing and synthetic biology, has enabled the production of more efficient and cost-effective ABC transporters.
Some of the major players in the ABC Transporter market include AbbVie, AstraZeneca, Bayer, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Additionally, there are a number of smaller companies, such as Aptevo Therapeutics, C4X Discovery, and Genentech, that are actively developing ABC transporters. Show Less Read more